Nonetheless, DOCK3 has been shown to be mutated in CRC tumors and might, according to a genetic principal component analysis, serve with a panel of other genes such as CACNA1D, SERPINB4, and ZBED6 as a subtype of CRC [39]. This evidence concerns the gene ZBED6 and colorectal carcinoma.